Trial finds limited benefit from fluid bolus before dog pericardiocentesis

Pericardiocentesis is the definitive emergency treatment for dogs with pericardial effusion causing tamponade, but clinicians have had limited prospective data to guide whether a pre-procedure crystalloid bolus helps stabilize these patients. In a randomized controlled trial published in the Journal of Veterinary Emergency and Critical Care, Nadine Jones, Karen Humm, and Erica W. Tinson compared a 10 mL/kg isotonic crystalloid bolus with no fluid therapy before pericardiocentesis in 30 dogs. The bolus was well tolerated and did not cause adverse respiratory effects, but it also did not significantly change shock index compared with no fluids before drainage. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary emergency and critical care teams, the study adds prospective evidence to a common stabilization question in dogs with cardiac tamponade. The findings suggest a modest crystalloid bolus can be used safely before pericardiocentesis when clinicians feel it’s indicated, while also reinforcing that fluid therapy shouldn’t be expected to replace or materially improve the hemodynamic benefit of prompt drainage. That fits with broader guidance that pericardiocentesis is the key intervention in tamponade, and that medical therapy alone is generally ineffective at reducing pericardial effusion. (pubmed.ncbi.nlm.nih.gov)

What to watch: Watch for larger studies that evaluate whether specific subgroups of dogs with tamponade, such as those with more severe shock or different underlying causes of effusion, derive measurable benefit from pre-pericardiocentesis fluid resuscitation. (pubmed.ncbi.nlm.nih.gov)